iRhythm Data Shows 26% Post-Ablation AF Recurrences, 60% Pregnancy Arrhythmias Detected After 48 Hours
Real-world data from 11,051 post-ablation patients show 26% of atrial fibrillation recurrences are first detected between 48 hours and 14 days using Zio ambulatory ECG monitoring. A parallel pregnancy study found 60% of arrhythmias and 66.7% of clinically significant events were first identified after 48 hours.
1. Post-Ablation Monitoring Study
In a nationwide retrospective analysis of 11,051 patients undergoing catheter ablation for atrial fibrillation, continuous Zio ambulatory ECG monitoring up to 14 days revealed an overall AF recurrence rate of 21%, with 26% of recurrences first detected after 48 hours, indicating short-term Holter monitoring would miss a substantial portion of events.
2. Pregnancy Arrhythmia Study
A separate retrospective review of pregnant patients monitored with Zio devices found arrhythmias in 37.7% of women and clinically significant events in 13.6%; 60% of all arrhythmias and 66.7% of significant events were first identified after 48 hours, highlighting underdiagnosis risks with standard 24–48 hour monitoring.
3. Limitations of Short-Duration Monitoring
These analyses demonstrate that relying on 24–48 hour Holter monitoring can misclassify up to 29.8% of post-ablation AF recurrences and miss a majority of pregnancy arrhythmias, potentially impacting anticoagulation decisions, repeat ablation considerations, and risk stratification.
4. Implications for Clinical Practice and iRhythm
The findings support updating clinical guidelines to recommend a minimum 14-day continuous monitoring period, which could drive wider adoption of Zio ambulatory ECG devices, enhance patient management in diverse populations, and boost iRhythm’s market penetration and revenue potential.